Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma

Clinical trial NCT00153920 · COMPLETED

Trial details

NCT number: NCT00153920
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2003-12-01
Primary completion: 2007-07-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.